Aurora-A kinase maintains the fidelity of early and late mitotic events in HeLa cells
about
sameAs
Tumor suppressor WARTS ensures genomic integrity by regulating both mitotic progression and G1 tetraploidy checkpoint functionInterphase nucleo-cytoplasmic shuttling and localization of SIRT2 during mitosisAurora A's Functions During Mitotic Exit: The Guess Who GameAurora at the pole and equator: overlapping functions of Aurora kinases in the mitotic spindleMLL5 maintains spindle bipolarity by preventing aberrant cytosolic aggregation of PLK1Aurora-A-Dependent Control of TACC3 Influences the Rate of Mitotic Spindle AssemblySpatial Compartmentalization Specializes the Function of Aurora A and Aurora B.Essential role for a novel population of binucleated mammary epithelial cells in lactation.Two TPX2-dependent switches control the activity of Aurora AContext-Dependent Cell Cycle Checkpoint Abrogation by a Novel Kinase InhibitorThe focal adhesion scaffolding protein HEF1 regulates activation of the Aurora-A and Nek2 kinases at the centrosomeHEF1-aurora A interactions: points of dialog between the cell cycle and cell attachment signaling networksRole of Filia, a maternal effect gene, in maintaining euploidy during cleavage-stage mouse embryogenesisSorcin links calcium signaling to vesicle trafficking, regulates Polo-like kinase 1 and is necessary for mitosisNDEL1 phosphorylation by Aurora-A kinase is essential for centrosomal maturation, separation, and TACC3 recruitmentAurora kinase-A deficiency during skin development impairs cell division and stratificationMultiple cancer testis antigens function to support tumor cell mitotic fidelity.Spatial exclusivity combined with positive and negative selection of phosphorylation motifs is the basis for context-dependent mitotic signaling.Ran is required before metaphase for spindle assembly and chromosome alignment and after metaphase for chromosome segregation and spindle midbody organization.MLN8054, a small-molecule inhibitor of Aurora A, causes spindle pole and chromosome congression defects leading to aneuploidy.A role for IkappaB kinase 2 in bipolar spindle assembly.Clathrin promotes centrosome integrity in early mitosis through stabilization of centrosomal ch-TOGAurora A kinase and its substrate TACC3 are required for central spindle assemblyCdk1 phosphorylates the Rac activator Tiam1 to activate centrosomal Pak and promote mitotic spindle formation.Deregulated ERK1/2 MAP kinase signaling promotes aneuploidy by a Fbxw7β-Aurora A pathwayGSK-3 inhibitors induce chromosome instability.Phase I study of MLN8237--investigational Aurora A kinase inhibitor--in relapsed/refractory multiple myeloma, non-Hodgkin lymphoma and chronic lymphocytic leukemia.Phase I study of the aurora A kinase inhibitor alisertib with induction chemotherapy in patients with acute myeloid leukemia.Aurora kinase inhibitors--rising stars in cancer therapeutics?Aurora kinase A is not involved in CPEB1 phosphorylation and cyclin B1 mRNA polyadenylation during meiotic maturation of porcine oocytesAurora kinase inhibitor ZM447439 blocks chromosome-induced spindle assembly, the completion of chromosome condensation, and the establishment of the spindle integrity checkpoint in Xenopus egg extracts.Clathrin heavy chain mediates TACC3 targeting to mitotic spindles to ensure spindle stability.Aurora kinases and protein phosphatase 1 mediate chromosome congression through regulation of CENP-E.Recognizing and exploiting differences between RNAi and small-molecule inhibitors.The aurora kinases in cell cycle and leukemiaThe Aurora-A inhibitor MLN8237 affects multiple mitotic processes and induces dose-dependent mitotic abnormalities and aneuploidyAurora A kinase modulates actin cytoskeleton through phosphorylation of Cofilin: Implication in the mitotic process.Kalanchoe tubiflora extract inhibits cell proliferation by affecting the mitotic apparatusSignificance estimation for sequence-based chemical similarity searching (PhAST) and application to AuroraA kinase inhibitors.Investigational Aurora A kinase inhibitor alisertib (MLN8237) as an enteric-coated tablet formulation in non-hematologic malignancies: phase 1 dose-escalation study.
P2860
Q24338515-68842935-D215-4CE0-AF39-50C8ABD79C6AQ24338619-8995CFAD-A98F-4EE6-80A3-ACA24AB79740Q26770572-BA5A9069-D8F9-43FF-9277-DFC2D4066BA7Q27021024-7255010C-9E47-4D83-B464-CC83348D0204Q27310288-4A2DFC25-DBEF-461D-AD0B-9E81A254F0BAQ27310808-ECA55986-AFFD-48A4-B9F4-F7791AB51ED3Q27312572-9D1676B1-1FB7-4E89-B351-0BF5F54B004CQ27318783-B8CB4643-5248-4436-8B80-2291F734E37EQ27437614-39B24702-09F5-47A2-9626-B6977B059B11Q27665373-01B9C079-BDD2-4638-87B3-5C3F6FE99309Q28273944-5611F255-930E-40FA-BD5C-1E4650480E9CQ28297459-B1E04F77-31FB-4222-B444-F4DEBC82DB1DQ28511214-158DA388-F193-4FDB-A2CA-AC45581375D9Q28538622-9BE69BA8-E704-4AFE-AD13-D72F9F4132C8Q28587157-6D72C682-8176-4433-AA14-B0543183F516Q28590357-4BD14A66-89E1-478A-8F22-B4EC7EEE92DDQ29871492-86ABD937-BB6B-4EBC-8B0C-02322844C1F3Q30414432-1C5C7632-9888-47F5-A9D8-37D75ABB512FQ30477054-B174DEDE-6518-4670-BEFB-5DA92BCEEE09Q30479689-A3C943CC-8A97-44C5-ACC6-4EB5D03C71BCQ30480263-565A511C-4F16-4BE1-A4FD-5C110F9B1A74Q30528931-F07D5322-41CA-4E5C-9CD6-29E2E9921FADQ30548057-D4B153E0-299D-4EA5-BFAA-02EB42F94C20Q30656511-F11E7AA1-9FF7-453D-89C5-5343BD003DF5Q30781182-5A5429CF-BD21-4F94-908D-2A13EFA5E127Q33294105-BCA27E3D-7129-4340-AC3D-C5CB2CF9EA75Q33412196-C5FA91EB-2597-4333-8BEE-BAE153FF626DQ33437992-DCB02202-8DA0-4852-AD59-7C3646934E27Q33647643-7BD0720C-84AC-45B0-BFE6-FBD84D40A3AEQ33830804-B62409D5-22A8-467B-9DC7-909FB797A929Q33914085-BAF4CBE3-2CE8-462C-B623-E2E866F5BB09Q33950281-6F35E032-3B2E-45AF-BCA5-8848680F979AQ34066062-87AD307A-88EE-47BB-AB02-D3BF1C0003A8Q34074675-36ABC30F-DBDF-4C82-A4BC-FCCA3079971EQ34203062-D33F60C4-B038-4843-98E9-75A73CDA8B98Q34227665-5BFBC7B4-8556-48DB-BD89-B42DA70AF90CQ34310944-29049127-0C6A-45FA-A372-68A5D76F15C9Q34410216-E6FDBA44-FFD0-47C9-A0AB-3D349964DB73Q34454041-3F2AA9A1-43A3-4CAC-917A-D2D962B8BEFAQ34498390-E36F566D-945B-4E78-99FB-BEC258F6F1E2
P2860
Aurora-A kinase maintains the fidelity of early and late mitotic events in HeLa cells
description
2003 nî lūn-bûn
@nan
2003 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Aurora-A kinase maintains the fidelity of early and late mitotic events in HeLa cells
@ast
Aurora-A kinase maintains the fidelity of early and late mitotic events in HeLa cells
@en
Aurora-A kinase maintains the fidelity of early and late mitotic events in HeLa cells
@nl
type
label
Aurora-A kinase maintains the fidelity of early and late mitotic events in HeLa cells
@ast
Aurora-A kinase maintains the fidelity of early and late mitotic events in HeLa cells
@en
Aurora-A kinase maintains the fidelity of early and late mitotic events in HeLa cells
@nl
prefLabel
Aurora-A kinase maintains the fidelity of early and late mitotic events in HeLa cells
@ast
Aurora-A kinase maintains the fidelity of early and late mitotic events in HeLa cells
@en
Aurora-A kinase maintains the fidelity of early and late mitotic events in HeLa cells
@nl
P2093
P2860
P3181
P356
P1476
Aurora-A kinase maintains the fidelity of early and late mitotic events in HeLa cells
@en
P2093
Eiji Kohmura
Hideyuki Saya
Masayuki Nitta
Shinobu Honda
Tomotoshi Marumoto
Toru Hirota
Toshihiro Hara
P2860
P304
P3181
P356
10.1074/JBC.M306275200
P407
P577
2003-12-19T00:00:00Z